
Cerus Corp
CERSNasdaqCIK 1020214HealthcareFiscal year ends Dec 31
Reports and events: 278 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-05-0417:09 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-017965 |
| 2023-05-0416:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-017869 |
| 2023-04-2812:51 ET | DEF 14A | Proxy statement | 0000950170-23-015609 |
| 2023-04-0516:06 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001193125-23-092216 |
| 2023-03-1017:26 ET | 8-K | 8.01 Other events | 0001193125-23-067785 |
| 2023-03-0116:24 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-005558 |
| 2023-02-2816:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-053823 |
| 2023-01-0908:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-004227 |
| 2022-11-0317:05 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021968 |
| 2022-11-0316:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-276881 |
| 2022-08-0417:02 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-014855 |
| 2022-08-0416:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-212492 |
| 2022-07-0516:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-187995 |
| 2022-06-0216:09 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-166216 |
| 2022-05-0517:02 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007920 |
| 2022-05-0516:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-142297 |
| 2022-05-0517:48 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-22-140749 |
| 2022-04-2212:06 ET | DEF 14A | Proxy statementPeriod 2022-06-01 | 0001193125-22-114637 |
| 2022-02-2217:14 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-001641 |
| 2022-02-2216:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-048529 |
| 2022-01-1008:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-005117 |
| 2021-12-2316:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-21-366192 |
| 2021-11-0217:16 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-053617 |
| 2021-11-0216:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-316919 |
| 2021-08-0317:01 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-040301 |
| 2021-08-0316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-234936 |
| 2021-06-0716:07 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-184290 |
| 2021-05-0417:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-023418 |
| 2021-05-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-149993 |
| 2021-04-2312:01 ET | DEF 14A | Proxy statementPeriod 2021-06-02 | 0001193125-21-128390 |
| 2021-03-3116:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-102269 |
| 2021-02-2517:20 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-008958 |
| 2021-02-2516:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-056933 |
| 2021-01-2917:16 ET | 8-K | 3.01 Delisting notice | 0001193125-21-022820 |
| 2021-01-1108:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-005848 |
| 2021-01-0616:02 ET | 8-K | 2.03 New direct financial obligation | 0001193125-21-003082 |
| 2020-12-1117:13 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-315995 |
| 2020-12-1116:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-315886 |
| 2020-10-2917:16 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-048950 |
| 2020-10-2916:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-281036 |
| 2020-08-0418:20 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-036218 |
| 2020-08-0416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-209290 |
| 2020-06-0816:17 ET | 8-K | 5.07 Shareholder vote results | 0001193125-20-163494 |
| 2020-05-2816:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-154257 |
| 2020-05-0517:28 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-021342 |
| 2020-05-0516:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-133699 |
| 2020-04-2412:01 ET | DEF 14A | Proxy statementPeriod 2020-06-03 | 0001193125-20-118592 |
| 2020-03-0216:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-058910 |
| 2020-02-2116:20 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-005756 |
| 2020-02-2016:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-043456 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 12:58 ET. Listed shows no prices and gives no investment advice.